Abstract
A series of 24 novel triazole-linked flavonol glycoconjugates 1~24 were synthesized using flavonols (Kaempferol, Rhamnocitrin or 7,5,4’-trimethoxy flavonol) and carbohydrates (glucose, galactose, lactose or maltose) as starting materials by a “Click chemistry” approach. Intermolecular Cu (I) catalyzed 1,3-dipolar cycloaddition of propargyl ethers of flavonols and glycosyl azides is the key step. Their cytotoxic potential against four human cancer cell lines (HL- 60, SMMC-7721, A-549 and MCF-7) was evaluated by standard MTT method. The results showed that 1, 3, 5, 6, 12 and 13 exhibit moderate to potent cytotoxicity against these cancer cell lines comparable with the positive control, cis- Platinum (DDP).
Keywords: Cytotoxic activity, Click chemistry, Flavonol, Glycoconjugates.
Letters in Organic Chemistry
Title:A Facile “Click Chemistry” Approach to Novel Flavonol Glycoconjugates and Their Cytotoxic Activity
Volume: 10 Issue: 9
Author(s): Wu Zheng, Nguyen Van-son, Liu Zhang-kun and Wang Qiu-an
Affiliation:
Keywords: Cytotoxic activity, Click chemistry, Flavonol, Glycoconjugates.
Abstract: A series of 24 novel triazole-linked flavonol glycoconjugates 1~24 were synthesized using flavonols (Kaempferol, Rhamnocitrin or 7,5,4’-trimethoxy flavonol) and carbohydrates (glucose, galactose, lactose or maltose) as starting materials by a “Click chemistry” approach. Intermolecular Cu (I) catalyzed 1,3-dipolar cycloaddition of propargyl ethers of flavonols and glycosyl azides is the key step. Their cytotoxic potential against four human cancer cell lines (HL- 60, SMMC-7721, A-549 and MCF-7) was evaluated by standard MTT method. The results showed that 1, 3, 5, 6, 12 and 13 exhibit moderate to potent cytotoxicity against these cancer cell lines comparable with the positive control, cis- Platinum (DDP).
Export Options
About this article
Cite this article as:
Zheng Wu, Van-son Nguyen, Zhang-kun Liu and Qiu-an Wang, A Facile “Click Chemistry” Approach to Novel Flavonol Glycoconjugates and Their Cytotoxic Activity, Letters in Organic Chemistry 2013; 10 (9) . https://dx.doi.org/10.2174/15701786113109990039
DOI https://dx.doi.org/10.2174/15701786113109990039 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiac Toxicity of Antineoplastic Anthracyclines
Current Medicinal Chemistry - Anti-Cancer Agents Dietary Antioxidants as Potential Pharmacological Agents for Ischemic Stroke
Current Medicinal Chemistry PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile
Current Pharmaceutical Design Stroke in Women
Recent Patents on Cardiovascular Drug Discovery Inflammation in Cardiovascular Disease and Regulation of the Actin Cytoskeleton in Inflammatory Cells: The Actin Cytoskeleton as a Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Effects and Mechanisms of Medicinal Plants on Healing Scars: A Systematic Review
Current Traditional Medicine Semisynthetic Hybrid Biopolymers for Non-pharmacological Intervention of the Microcirculation
Current Drug Metabolism Potential Role of Inflammation in Associations between Particulate Matter and Heart Failure
Current Pharmaceutical Design IL-6, IL-1β, and MDA Correlate with Thrombolysis in Myocardial Infarction (TIMI) Risk Score in Patients with Acute Coronary Syndrome
Recent Advances in Inflammation & Allergy Drug Discovery A Simple and Rapid Method for Expression and Purification of Functional TNF-α Using GST Fusion System
Current Pharmaceutical Biotechnology Programmed Cell Death after Intracerebral Hemorrhage
Current Neuropharmacology Cerebrovascular Endothelin Receptor Upregulation in Cerebral Ischemia
Current Vascular Pharmacology Evaluation of Novel Biomarkers of Acute Kidney Injury: The Possibilities and Limitations
Current Medicinal Chemistry Irreversible Inhibition of Serine Proteases – Design and In Vivo Activity of Diaryl α-Aminophosphonate Derivatives
Current Medicinal Chemistry Perspective of Molecular Hydrogen in the Treatment of Sepsis
Current Pharmaceutical Design Preeclampsia: Placental Origins, New Predictors and New Therapeutic Strategies
Current Women`s Health Reviews The Emerging Role of Coenzyme Q-10 in Aging, Neurodegeneration, Cardiovascular Disease, Cancer and Diabetes Mellitus
Current Neurovascular Research Mechanisms to Inhibit Matrix Metalloproteinase Activity: Where are we in the Development of Clinically Relevant Inhibitors?
Recent Patents on Anti-Cancer Drug Discovery Blocking Leukocyte Rolling: Does it have a Role in Disease Prevention?
Vascular Disease Prevention (Discontinued) Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry